Anil Wali, Ph.D.

Program Director

National Cancer Institute (NCI), NIH

Contact

Anil Wali is a Program Director in the Integrated Networks Branch of the NCI’s CRCHD since 2009. In this role, Dr. Wali contributes to the grants management of CRCHD’s Geographic Management of Cancer Health Disparities Program. He also provides technical and scientific expertise to the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE U54) program.

Prior to joining NCI, Dr. Wali served as Associate Professor in the Departments of Surgery and Pathology at the NCI-designated Comprehensive Cancer Center Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit Michigan. While at Wayne State University, Dr. Wali served as Principal Investigator on a Veterans Administration Merit Review award funded project on the Role of Ubiquitin-Proteasome Pathway in Mesothelioma Carcinogenesis. Dr. Wali conducted NCI Clinical trial on asbestos exposed patient populations to determine their risk for developing Lung Cancer and Mesothelioma using high throughput Genomics and Proteomics technologies.

Dr. Wali received his B.S. and M.S. degrees from the University of Kashmir, in Srinagar, India. He earned his Ph.D. at the Postgraduate Institute in Chandigarh, India. Dr. Wali completed postdoctoral fellowships at the Institute for Environmental Medicine at the University of Pennsylvania; at the FELS Institute for Cancer Research at Temple University, Philadelphia, PA; and in the Department of Pathology at Thomas Jefferson University, Philadelphia, PA.


Related Sessions

View full schedule